These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 24818887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
    Zhang S, Tang C, Yin C.
    Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy.
    Zheng H, Tang C, Yin C.
    Biomaterials; 2015 Nov; 70():126-37. PubMed ID: 26310108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H.
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [Abstract] [Full Text] [Related]

  • 9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z, Huang J, Xu Y, Zhang X, Teng Y, Huang C, Wu Y, Zhang X, Zhang H, Sun W.
    Oncotarget; 2015 Dec 08; 6(39):42150-68. PubMed ID: 26517524
    [Abstract] [Full Text] [Related]

  • 10. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L, Tang C, Yin C.
    Biomaterials; 2014 May 08; 35(15):4589-600. PubMed ID: 24613049
    [Abstract] [Full Text] [Related]

  • 11. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J, Liu Y, Zhang L, Zhao J, Ren J, Zhang L, Jin Y.
    J Biomater Sci Polym Ed; 2015 May 08; 26(18):1475-89. PubMed ID: 26489688
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hexanoic acid and polyethylene glycol double grafted amphiphilic chitosan for enhanced gene delivery: influence of hydrophobic and hydrophilic substitution degree.
    Layek B, Haldar MK, Sharma G, Lipp L, Mallik S, Singh J.
    Mol Pharm; 2014 Mar 03; 11(3):982-94. PubMed ID: 24499512
    [Abstract] [Full Text] [Related]

  • 18. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J, Tang C, Yin C.
    Acta Biomater; 2017 Jan 01; 47():81-90. PubMed ID: 27729232
    [Abstract] [Full Text] [Related]

  • 19. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
    He R, Yin C.
    Acta Biomater; 2017 Apr 15; 53():355-366. PubMed ID: 28189812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.